Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.491, 2005-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Trastuzumab: throwing caution to the wind in breast cancer?
Inpharma, Vol. 1, Iss. 1514, 2005-01 ,pp. :
Access to resources
Recommend
Bisphosphonates: are they useful in breast cancer?
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
Adjuvant trastuzumab for breast cancer that overexpresses HER2?
Inpharma, Vol. 1, Iss. 1280, 2001-01 ,pp. :
Is There a Growing Role for Endocrine Therapy in the Treatment of Breast Cancer?
By Lønning P.E.
Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. :
Abraxane the best taxane for metastatic breast cancer?
Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. :